Log In
BCIQ
Print this Print this
 

BreathID

  Manage Alerts
Collapse Summary General Information
Company Exalenz Bioscience Ltd.
DescriptionBreath-based diagnostic that measures liver function
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics: Other diagnostic technologies
Latest Stage of DevelopmentPivotal
Standard IndicationHepatic, Diagnostic
Indication DetailsDiagnose clinically significant portal hypertension (CSPH) in patients with chronic liver disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today